Rajan Sharma
Stock Analyst at Goldman Sachs
(0.16)
# 4,376
Out of 5,058 analysts
5
Total ratings
25%
Success rate
-23.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rajan Sharma
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reinstates: Sell | $7.25 | $13.77 | -47.35% | 1 | May 29, 2025 | |
| AZN AstraZeneca | Initiates: Buy | $97 | $88.68 | +9.38% | 1 | May 30, 2024 | |
| GSK GSK plc | Initiates: Neutral | $47 | $46.11 | +1.93% | 1 | May 30, 2024 | |
| IMCR Immunocore Holdings | Reiterates: Overweight | $79 | $39.01 | +102.51% | 2 | Jun 20, 2023 |
DBV Technologies
May 29, 2025
Reinstates: Sell
Price Target: $7.25
Current: $13.77
Upside: -47.35%
AstraZeneca
May 30, 2024
Initiates: Buy
Price Target: $97
Current: $88.68
Upside: +9.38%
GSK plc
May 30, 2024
Initiates: Neutral
Price Target: $47
Current: $46.11
Upside: +1.93%
Immunocore Holdings
Jun 20, 2023
Reiterates: Overweight
Price Target: $79
Current: $39.01
Upside: +102.51%